Literature DB >> 9650943

Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples.

M Denton1, N J Todd, K G Kerr, P M Hawkey, J M Littlewood.   

Abstract

Stenotrophomonas maltophilia was isolated from the respiratory tracts of 41 (25%) of 163 children attending our pediatric cystic fibrosis unit between September 1993 and December 1995. The extents of S. maltophilia contamination of environmental sites frequented by these patients were investigated with a selective medium incorporating vancomycin, imipenem, and amphotericin B. Eighty-two isolates of S. maltophilia were cultured from 67 different environmental sites sampled between January and July 1996. The organism was widespread in the home environment, with 20 (36%) and 25 (42%) of sampled sites positive in the homes of colonized and noncolonized patients, respectively. In the nosocomial setting, it was isolated from 18 (32%) sites in the hospital ward and from 4 (17%) sites in the outpatient clinic area. The most common sites of contamination were sink drains, faucets, and other items frequently in contact with water. All environmental and clinical isolates were genotyped with enterobacterial repetitive intergenic consensus sequences as primers. A total of 33 of the 41 patients were colonized with unique strains, and four pairs of patients shared strains. Further characterization by pulsed-field gel electrophoresis after digestion with XbaI found that there was no evidence of patient-to-patient transmission; however, there was some evidence that a small number of patients may have acquired the organism from the hospital environment. Resampling of environmental sites in the hospital ward in January 1997 revealed evidence of genetic drift, complicating the accurate determination of environmental sources for clinical strains. The source of the majority of S. maltophilia strains colonizing the respiratory tracts of these patients with cystic fibrosis remained uncertain but may have represented multiple, independent acquisitions from a variety of environmental sites both within and outside the hospital.

Entities:  

Mesh:

Year:  1998        PMID: 9650943      PMCID: PMC104959     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Aerosol polymyxin and pneumonia in seriously ill patients.

Authors:  T W Feeley; G C Du Moulin; J Hedley-Whyte; L S Bushnell; J P Gilbert; D S Feingold
Journal:  N Engl J Med       Date:  1975-09-04       Impact factor: 91.245

2.  A one-step microbial DNA extraction method using "Chelex 100" suitable for gene amplification.

Authors:  X de Lamballerie; C Zandotti; C Vignoli; C Bollet; P de Micco
Journal:  Res Microbiol       Date:  1992-10       Impact factor: 3.992

3.  Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients.

Authors:  M E Villarino; L E Stevens; B Schable; G Mayers; J M Miller; J P Burke; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1992-04       Impact factor: 3.254

4.  Pseudomonas septicemia due to deficient disinfectant mixing during reuse.

Authors:  R Vanholder; E Vanhaecke; S Ringoir
Journal:  Int J Artif Organs       Date:  1992-01       Impact factor: 1.595

5.  Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant.

Authors:  M M Wishart; T V Riley
Journal:  Med J Aust       Date:  1976-11-06       Impact factor: 7.738

6.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Production of volatile nitrogenous compounds from the degradation of streptomycin by Pseudomonas maltophilia.

Authors:  J J Fenton; H H Harsch; D Klein
Journal:  J Bacteriol       Date:  1973-12       Impact factor: 3.490

8.  An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers.

Authors:  J P Flaherty; S Garcia-Houchins; R Chudy; P M Arnow
Journal:  Ann Intern Med       Date:  1993-12-01       Impact factor: 25.391

9.  Pseudomonas maltophilia bacteremia in children undergoing open heart surgery.

Authors:  M C Fisher; S S Long; E M Roberts; J M Dunn; R K Balsara
Journal:  JAMA       Date:  1981-10-02       Impact factor: 56.272

10.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more
  36 in total

1.  In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; M Fortuna; D Drenaggi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Molecular epidemiology of Stenotrophomonas maltophilia isolated from cystic fibrosis patients.

Authors:  Miles Denton; Kevin G Kerr
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.

Authors:  M Hogardt; K Trebesius; A M Geiger; M Hornef; J Rosenecker; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  A cyclic AMP receptor protein-regulated cell-cell communication system mediates expression of a FecA homologue in Stenotrophomonas maltophilia.

Authors:  Tzu-Pi Huang; Amy C Lee Wong
Journal:  Appl Environ Microbiol       Date:  2007-06-15       Impact factor: 4.792

Review 6.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 7.  Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.

Authors:  Reshma Amin; Valerie Waters
Journal:  Cochrane Database Syst Rev       Date:  2016-07-14

8.  Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

Authors:  Hsiao-Chuan Chang; Chiy-Rong Chen; Juey-Wen Lin; Gwan-Han Shen; Kai-Ming Chang; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients.

Authors:  S Horster; L Bader; U Seybold; I Eschler; K G Riedel; J R Bogner
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

Review 10.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.